Delirium, Dementia, Amnestic, Cognitive Disorders  >>  blarcamesine (Anavex 2-73)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
blarcamesine (Anavex 2-73) / Anavex
ANAVEX, NCT02244541: Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of 2-73 in Patients With Alzheimer's Disease

Checkmark At CTAD 2016
Dec 2016 - Dec 2016: At CTAD 2016
Checkmark At CTAD 2016
Dec 2016 - Dec 2016: At CTAD 2016
Checkmark
More
Completed
2a
32
RoW
ANAVEX2-73 Oral, ANAVEX2-73 Intravenous
Anavex Life Sciences Corp.
Alzheimer's Disease
11/15
11/16

Download Options